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Abstract  
Objective: Meta-analyses have documented the efficacy of cognitive-behavioural therapy 
(CBT) for reducing symptoms of eating disorders. However, it is not known whether CBT for 
eating disorders can also improve quality of life (QoL). This meta-analysis therefore 
examined the effects of CBT for eating disorders on subjective QoL and health-related 
quality of life (QoL). Method: Studies that assessed QoL before and after CBT for eating 
disorders were searched in the PsycInfo and Medline database. Thirty-four articles met 
inclusion criteria. Pooled within and between-groups Hedge’s g were calculated at post-
treatment and follow-up for treatment changes on both subjective and HRQoL using a 
random effects model. Results: CBT led to significant and modest improvements in 
subjective QoL and HRQoL from pre to post-treatment and follow-up. CBT led to greater 
subjective QoL improvements than inactive (i.e., wait-list) and active (i.e., a combination of 
bona fide therapies, psychoeducation) comparisons. CBT also led to greater HRQoL 
improvements than inactive, but not active, comparisons. Pre-post QoL improvements were 
larger in studies that delivered CBT individually and by a therapist or according to the 
cognitive maintenance model of eating disorders (CBT-BN or CBT-E); though this was not 
replicated at follow-up Conclusions: Findings provide preliminary evidence that CBT for 
eating disorders is associated with modest improvements in QOL, and that CBT may be 
associated with greater improvements in QOL relative to comparison conditions.  
Keywords: Eating disorders; Quality of Life; Cognitive-behavioural therapy 
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The Effects of Cognitive-Behavioural Therapy for Eating Disorders on Quality of Life: A 
Meta-Analysis 
 Eating disorders are highly prevalent, chronic and disabling conditions that negatively 
impacts an individual’s quality of life (QoL) 1. Individuals with eating disorders consistently 
report a poorer QoL than healthy controls 2,  and studies have reported greater QoL 
impairments in individuals with eating disorders relative to other mental health conditions 
(e.g., mood disorders)3 and to several common medical disorders (e.g., angina and cystic 
fibrosis)4. 
QoL is a multidimensional construct encompassing physical, psychological and social 
dimensions of health5. There are several approaches to measuring QoL. One approach is to 
assess QoL through objective indicators (e.g., income level, housing status), generally by 
reference to the standing of an individual to the population 6. Other approaches of assessing 
QoL are through self-report questionnaires. Many QoL measures assess an individual’s sense 
of wellbeing, satisfaction with life, and overall happiness 7. This assessment of QoL is 
typically referred to as subjective QoL7. Subjective QoL can be a global measure of 
wellbeing or satisfaction, or it can be broken down into distinct domains (e.g., social 
wellbeing). Subjective QoL measures typically used within eating disorder populations 
include the Social Adjustment Scale, the Questionnaire on Life Satisfaction, and the Quality 
of life Enjoyment and Satisfaction Questionnaire. Unlike subjective QoL, health-related 
quality of life (HRQoL), which is also assessed via self-report, assesses one’s life specifically 
in relation to physical, psychological, and social health. HRQoL is composed of both 
“generic” and “disease-specific” measures. Generic measures (e.g., Short-Form 36) can be 
applied to anyone and are generally used to make comparisons across conditions and 
populations 7. Generic measures can also be used as a global measure or it can also be broken 
down into specific domains (e.g., physical and mental HRQoL). Conversely, disease-specific 
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measures are designed to assess HRQoL in a specific populations, with the intention of 
assessing impairment peculiar to specific psychopathology7. Both generic and disease-
specific measures are recommended for use in eating disorder research; generic measures 
allow for QoL comparisons across several populations (e.g., healthy controls, psychiatric 
populations) while eating disorder-specific measures are designed to rule out the confluence 
of comorbid psychopathology on QoL and are also more sensitive to change8.  
Cognitive-behavioural therapy (CBT) is effective for reducing symptoms of eating 
disorders. While several distinct cognitive-behavioural treatment protocols and formats (e.g., 
day-patient, inpatient, self-help) for eating disorders exist, a specific form of therapist-led 
manualised CBT (CBT-BN) is the leading evidence-based treatment for bulimia nervosa 
(BN) and binge eating 9. CBT-BN is based on a cognitive maintenance model of BN and it 
has recently been revised so it is suitable for the treatment of all eating disorders (CBT-E)10. 
Given the superior effects of CBT-BN at reducing eating disorder symptoms relative to 
alternate psychological and pharmacological treatments, international treatment guidelines 
recommend CBT-BN as the first-line of treatment for certain eating disorders11. 
While eating disorder symptom reduction is critical for determining CBTs success, 
individuals with eating disorders typically seek treatment because of the debilitating effect 
their condition has on their QoL12. Thus, there has been a recent focus on assessing treatment 
outcomes in terms of both symptom reduction and improvements in QoL8. Several studies 
have assessed the impact of CBT for eating disorders on subjective and HRQoL, and a 
generally consistent finding is that QoL improves immediately following CBT13, 14. However, 
QoL changes following CBT— and eating disorder treatment in general — has received 
minimal research attention, and key questions remain unanswered. For instance, it is not 
known (1) what the magnitude of QoL improvements immediately following CBT are; (2) 
whether improvements in QoL following CBT are sustained over the long-term; (3) whether 
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CBT is more effective at improving QoL in the short and long-term than both active and 
inactive comparisons.  
 The current meta-analysis aims to address this gap by examining (a) if, and to what 
extent, CBT for eating disorders improves QoL in the short and long-term and (b) whether 
CBT is superior to alternative psychological treatments at improving QoL in the short and 
long-term. We also aim to test whether the effects of CBT on QoL are moderated by certain 
study characteristics, including (1) diagnosis, (2) study design, (3) treatment modality 
(individual, group, self-help), (4) treatment format (CBT-BN or CBT-E vs. other), (5) study 
quality, and (6) analysis reported (completer, intention to treat).  
Method 
This review was conducted according to the Preferred Reporting Items for Systematic 
Reviews and Meta-analysis (PRISMA) guidelines15. 
Search Strategy 
 The primary search strategy involved searching the PsycInfo and Medline database in 
December 2016. The following two sets of terms were searched simultaneously using the 
AND Boolean operator; (a) “eating disorder” OR bulimi* OR anorexi* OR binge* OR 
EDNOS; (b) CBT* or “cognitive-behav*” OR “cognitive behav*. The secondary search 
strategy involved searching the reference list of included papers and relevant reviews.  
Inclusion and Exclusion Criteria 
 Included studies were those that (a) administered CBT that was specifically designed 
to treat eating disorders, (b) in an adult eating disorder sample, (c) that included at least one 
measure of QoL at pre-treatment and post-treatment or follow-up, (d) and was published in 
English and in a peer-review journal. Excluded studies were that that (a) administered a 
multidisciplinary treatment that included components of CBT in combination with other 
psychological or pharmacological treatments; (b) administered CBT weight loss 
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interventions; (c) administered purely behavioural treatments or third-wave cognitive-
behavioural treatments (e.g., Acceptance and Commitment Therapy, Dialectical Behaviour 
Therapy), since these treatments distinguish themselves from CBT by focusing on different 
aspects and perusing a different treatment goal. Although RCTs are the best method for 
testing a treatments efficacy, due to the limited published studies that have assessed QoL 
change, we included both prospective controlled and uncontrolled designs. This allowed us to 
calculate both uncontrolled (i.e., pre-post change) and controlled effect sizes (i.e., comparison 
between conditions). Because we are aware of the limitations of uncontrolled effect sizes 16, 
we ensured that our controlled effect sizes were based on the available RCTs.  
Study Selection 
The search strategy outputs from the databases were combined. Duplicates were 
removed. Titles and abstracts were screened to determine whether the study was related to the 
research question. To maximise identification of relevant articles, the full-text of any study 
that administered CBT for eating disorders was read entirely to determine eligibility. This 
was because QoL is typically a secondary outcome reported and is often not mentioned in the 
title or abstract when it is reported in text. Articles that met inclusion criteria were screened 
to determine eligibility for meta-analysis. Authors of articles that did not provide sufficient 
data to calculate an effect size were contacted. Both authors discussed studies for which 
inclusion was uncertain. A total of 34 articles met full inclusion criteria. Thirty-three articles 
were included in the meta-analysis (one paper17 did not provide sufficient data to calculate an 
effect size). A flowchart of the search strategy is presented in Figure 1. 
Quality Assessment  
The quality of included studies was assessed using the Quality Assessment Tool for 
Quantitative Studies developed by the Effective Public Health Practice Project (EPHPP) 18. 
This assessment tool was deemed suitable for systematic reviews on intervention 
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effectiveness, and can be used for RCTs and pre-post designs18. Content and construct 
validity has been established19. A rating of “strong”, “moderate” or “weak” methodological 
quality was assigned to each of the following six different domains: (1) selection bias; (2) 
study design; (3) confounders; (4) blinding; (5) data collection methods; (6) withdrawals and 
drop-outs. Then, a global quality rating was made based on the ratings from the six domains. 
Studies that received no “weak” domain ratings were rated as “strong” quality, while those 
with one “weak” rating were rated as “moderate” quality, and those with two or more “weak” 
ratings were rated as “weak” quality. Any discrepancies were discussed among authors until a 
consensus was reached. Given the limited number of included studies, and consistent with 
previous meta-analyses, studies were not excluded based on their quality rating.  
Data Extraction  
 The following information was extracted from the included studies: Diagnostic type; 
sample size; study design; CBT modality (individual therapist-led, group, self-help) and type 
(based on the cognitive maintenance model, CBT-BN/CBT-E, or not); comparison treatment 
(active or inactive); length of follow-up; QoL measure; analysis reported (completer or ITT); 
any data that would permit calculation of an effect size.  
Effect Size Calculation and Data Synthesis  
 Primary analyses were conducted for post-treatment and follow-up subjective QoL 
and HRQoL changes. For studies that reported multiple follow-up points, effect sizes were 
calculated for the last reported follow-up. ITT data were prioritised over completer data,  
For within-subject designs (pre-post change or pre to follow-up change), the 
standardised mean gain was calculated by dividing the difference between the post-treatment 
(or follow-up) and pre-treatment QoL mean by the pooled standard deviation21. Effect sizes 
were then converted to Hedge’s g to correct for biases due to small sample sizes22. The 
standard error is needed to correct for these biases. To obtain the standard error in repeated 
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measures designs, the correlation between pre-treatment and post-treatment (or follow-up) 
QoL score is needed. However, r was not reported in included studies. Thus, we used the test 
retest reliability of the relevant scale published in separate studies21. Then, to calculate a 
pooled effect size, each studies overall effect size was weighted by its inverse variance. A 
positive g indicates QoL improvements from pre to post treatment/follow-up. A negative g 
indicates decrements in QoL from pre to post-treatment/follow-up. Small (0.2), medium (0.5) 
and large (0.8) effects are specified.  
For between-subject designs (CBT versus comparisons), the standardised mean 
difference, d, was initially calculated by dividing the difference between the post-treatment 
(or follow-up) CBT group mean and the post-treatment (or follow-up) comparison group 
mean by the pooled standard deviation21. D was also converted to Hedge’s g to account for 
sample size and pooled effect sizes were calculated by weighing each effect size by its 
inverse variance. Relative to comparison conditions, positive g indicates that CBT was 
associated with a greater QoL while a negative g indicates that CBT was associated with a 
lower QoL. One included study administered interpersonal psychotherapy (IPT) and 
behaviour therapy (BT) as comparison treatments23. For this study, we computed an effect 
size comparing CBT to IPT, as across included studies IPT was administered more often as a 
comparison treatment.  
At times, multiple effect sizes were calculated from the same study. This occurred 
when studies reported data for several subjective QoL or several HRQoL measures, or when 
studies compared multiple CBT conditions (e.g., self-help, therapist-led) to a control 
condition. Including multiple effect sizes from the same study biases the overall effect size 
estimate24. To maintain statistical independence, we computed separate effect sizes for each 
subjective or HRQoL measure or for CBT control comparison, and then aggregated these 
estimates to produce an overall effect size for that study. Although we intended on analysing 
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the effects of CBT on specific subjective and HRQoL domains (e.g., physical and mental 
domains), this was not feasible because too few studies used measures that assess these 
separate domains. For the few studies that assessed multiple domains, an aggregated effect 
size combining these domains on either subjective or HRQoL was computed.  
Heterogeneity and Moderator Analyses  
To calculate the pooled effect sizes, the Comprehensive Meta-Analysis program was 
used. For primary analyses, a random effects model was used over a fixed effects model. In 
the fixed effects model, it is assumed that all studies in the meta-analysis are homogenous 
and are essentially replications of each other. In the random effects model, however, it is 
assumed that all included studies can be seen as a sample drawn from the population. 
Compared to the fixed effects model, the random effects model produces wider 95% 
confidence intervals, which means that it typically produces more conservative test 
statistics24. Heterogeneity was assessed using the Q and I2 statistic. The Q statistic assesses 
the presence of heterogeneity, while the I2 statistic assesses the degree of heterogeneity, 
ranging from zero (complete homogeneity) to 100 (complete heterogeneity)25. 
Since heterogeneity was expected, we examined whether the effect sizes were 
moderated by study characteristics. For each subgroup, a pooled effect size is calculated, and 
a test is conducted to examine whether subgroup effect sizes differ significantly from each 
other. A mixed effects model was used, which pools studies within subgroups using a random 
effects model, but tests for significant differences between subgroups using a fixed effects 
model24. Mixed effects models are generally a conservative approach for testing moderation 
effects, and are widely used in meta-analytic research. However, it is important to note that 
the use of mixed effect models has been criticised for failing to detect true effects when the 
number studies contributing to an analysis is low26. Rather, some have suggested that 
estimations based on Bayesian procedures are more appropriate, as Bayesian calculations 
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have been shown to be more stable and powerful in meta-analyses with a small number of 
studies. However, Bayesian procedures require knowledge of a prior distribution (the range 
of possible values) for τ, which is often not known26, 27. Statistically significant differences 
between subgroups are denoted by the Qbetween statistic. The following categorical 
moderators were examined for both the within and between-group analyses: 
Diagnosis. A transdiagnostic, BN, anorexia nervosa (AN), or binge eating disorder 
(BED) sample.  
 CBT modality. Individual therapist-led CBT, group CBT, or CBT self-help.  
 CBT type. CBT that was based on the cognitive maintenance model of eating 
disorders (i.e., CBT-BN28 or CBT enhanced29), or an alternative CBT approach.  
 Quality rating. Strong, moderate, or weak quality rating.  
 Analysis reported. ITT or completer data reported.  
 Study design. Controlled study or a pre-post design (only for within groups 
analyses).  
 Comparison type. Delivery of an inactive (e.g., wait-list) condition or active 
comparison treatment (only for between groups analyses). 
Publication Bias 
The Fail-Safe N was calculated to address potential publication bias30. The Fail-Safe 
N estimates how many missing studies would need to be included in the meta-analysis for the 
effect size to become statistically non-significant. An effect is considered robust to 
publication bias if N is greater than 5K + 10, where K is the number of studies included in the 
analysis30. 
Results  
Study Characteristics  
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Thirty-four papers met full inclusion criteria. Effect sizes could not be calculated for 
one paper17, so 33 papers were included in the meta-analysis. Table 1 and 2 presents the 
characteristics of the included RCTs and non-RCTs, respectively. The majority of studies 
received a “moderate” quality rating (k= 17) followed by “strong” (k= 11) and then “weak” 
quality ratings (k= 6). See Table 1 and 2 for domain and global quality ratings for each study. 
Of the 33 studies, 23 were RCTs, one was an uncontrolled study, and 9 were single treatment 
pre-post designs. Of the 24 studies that included a comparison condition, nine used a wait-list 
control while 12 administered an active comparison. The most common active comparison 
treatment was IPT (k=4); other active comparisons included Emotion and Social Mind 
Training, Behavioural Weight Loss, Specialist Supportive Clinical Management, 
Psychoeducation, Supportive Expressive Therapy, Multidisciplinary Specialist Treatment, 
Treatment as Usual and Short-term Focal Psychotherapy (all k’s=1).The most frequent mode 
of delivery was individual therapist-led (k=14) followed by guided self-help (k=11) and then 
group CBT (k=9)1. Majority of studies used a transdiagnostic sample (k=14), followed by BN 
(k=8) BED (k=9) and AN (k=2).  
The most commonly used subjective QoL measure was the Social Adjustment Scale 
(k= 10) followed by the Questionnaire on Life Satisfaction (QLS; k= 3), Satisfaction with 
Life Scale (k=2), Work and social Adjustment Scale (k=2), Quality of Life Enjoyment and 
Satisfaction Questionnaire – Short Form (QLESQ; k=2), EuroQol visual analogue scale 
(k=1), and the Quality of Life Index – Spanish Version (k=1). Only two generic HRQoL 
measures were reported across studies, with three studies reporting the Short-Form 36 and 
one study reporting the World Health Organisation QoL scale. Several studies assessed eating 
disorder-specific HRQoL measures, with the Clinical Impairment Assessment (k= 6) being 
the most frequently reported measure, followed by the Impact of Weight on Quality of Life 
                                                             
1 One study administered both an individual therapist-led and a guided self-help CBT.  
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Scale (k=4) and the Quality of Life in Eating Disorders Scale (k=1). No study assessed 
objective indicators of QoL.   
Within-Group Effect Size 
 Pre-post effect size. For the within-group pre-post analysis on subjective QoL (Ncomp 
= 20, N= 1,044 participants), the random effects model produced a statistically significant, 
medium effect size of g = 0.50 (95% CI = 0.38, 0.62), v= .001, p<.001 (see Figure 2). The 
Fail-Safe N was 2725 indicating no publication bias. . There was significant heterogeneity, Q 
= 59.23, p<.001, I2 = 67.92. The SAS (Ncomp = 13) was the most commonly used measure of 
subjective QoL, and when we analysed the pre-post effect of SAS scores, the pooled effect 
size was g= 0.57 (95% CI= 0.43, 0.71), v= .005. The QLESQ (Ncomp=2, g= 0.43, 95% CI 
[0.32, 0.54], v=.003) and the QLS (Ncomp= 2, g= 0.33, 95% CI [0.11, 0.55], v=.013) was also 
used in more than one study, and significant small to medium effect sizes were observed.  
For HRQoL (Ncomp = 16, N = 717 participants), the random effects model produced a 
statistically significant, medium effect size of g = 0.55 (95% CI = 0.42, 0.69), v=.007, p<.001 
(See Figure 2). There were no indications of publication bias (Fail-Safe N = 3986). There was 
significant heterogeneity present, Q = 370.78, p<.001, I2= 95.95. For eating disorder-specific 
measures (Ncomp=11), a statistically significant medium effect size was observed (g = 0.58 
[95% CI = .39, .77], v=.009). When the CIA (Ncomp= 5) was used as a measure of eating 
disorder-specific HRQoL, a significant large effect size was observed (g= 0.80, 95% CI 
[0.49, 1.15], v=.028). When the IWQoL was used (Ncomp= 5), a significant small effect size 
was observed (g= 0.34, 95% CI [0.23, 0.44], v=.003).  For generic HRQoL measures 
(Ncomp=4), a significant medium effect was observed (g= .50 [95% CI = .33, .76], v=.008). 
When the SF-36 was used as a measure of generic HRQoL (Ncomp=3), a significant medium 
effect size was observed (g= 0.47, 95% CI [0.26, 0.67], v=.011).  
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 We then conducted moderator analyses on both the subjective QoL and HRQoL 
pooled effect size to try and explain the statistical heterogeneity. Table 3 presents the pooled 
effect size for each subgroup across both subjective and HRQoL measures. Significant 
differences between subgroups are denoted by the Qbetween statistic. Several moderation 
effects were observed.  
 First, the effect size for subjective QoL was significantly larger for studies that 
administered individual therapist-led CBT as opposed to studies that administered group CBT 
or self-help CBT. Second, the effect size for both subjective and HRQoL was significantly 
larger for studies that reported completer data as opposed to ITT data. Third, the effect size 
for HRQoL was significantly larger for studies that used a transdiagnostic sample as opposed 
to studies that used a BN or AN sample. Finally, the effect size for HRQoL was significantly 
larger for studies that administered CBT based on the cognitive maintenance model (CBT-
BN or CBT-E) as opposed to studies that administered an alternative CBT type (See Table 3).  
 Pre-treatment to follow-up effect size. The random effects model for subjective QoL 
(Ncomp = 11, N = 400 participants) produced a statistically significant large effect size of g = 
0.81 (95% CI = 0.63, 0.99), v= .009, Z = 8.73, p<.001. There were no indications of 
publication bias (Fail-Safe N = 1065) and there was significant heterogeneity present, Q = 
52.15, p<.001, I2= 80.82. When the SAS was used as a measure of outcome (Ncomp= 7), a 
significant medium effect size was also observed (g= 0.67, 95% CI [0.54, 0.82], v=.005). A 
significant large effect (g= 1.32, 95% CI [0.16, 2.46], v=.337) was also observed when the 
QLS was used as an outcome (Ncomp=2).  
For HRQoL (Ncomp =11, N= 474 participants), the random effects model produced a 
statistically significant medium effect size of g = 0.52 (95% CI = 0.27, 0.77), v=.016, Z = 
4.08, p<.001. There were no indications of publication bias (Fail-Safe N =1121) and there 
was significant heterogeneity, Q = 276.29, p<.001, I2= 96.74. For eating disorder-specific 
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measures (Ncomp=6), a statistically significant medium effect size was observed (g= 0.61, 
[95% CI = .28, .94], v=.028). When the IWQoL was used as an outcome (Ncomp= 5), and a 
significant medium effect was also observed (g= 0.48, 95% CI [0.23, 0.73], v=.016). For 
generic HRQoL (Ncomp=4), a significant small effect was observed (g= 0.37 [95% CI = 0.16, 
0.59], v=.012). When the SF-36 was used as an outcome (Ncomp=3), a significant small effect 
size was observed (g= 0.25, 95% CI [0.06, 0.44], v=.009).  
 Subgroup analyses were also performed for analyses examining subjective QoL and 
HRQoL changes from pre-treatment to follow-up (Table 3). The effect size for HRQoL at 
follow-up was significantly larger for studies that reported completer data compared to 
studies that reported ITT data. The effect size for HRQoL at follow-up was also significantly 
smaller for studies that received a medium quality rating as opposed to studies that received a 
strong or weak quality rating. No other significant moderator effects were observed.  
Between-Group Effect Size  
 Post-treatment effect size. When comparing CBT to any comparison (active or 
inactive) condition, the between groups random effects model for subjective QoL produced a 
statistically significant small effect of g = 0.39 (95% CI = 0.20, 0.57), v= .009, p<.001 (Ncomp 
= 13, N=1,108 participants, Figure 3). There were no indications of publication bias (Fail-
Safe N = 112) and there was significant heterogeneity, Q= 27.03, p= .007, I2= 56.09. When 
the SAS was used as an outcome (Ncomp = 8), a significant small effect size was also observed 
(g= 0.28, 95% CI [0.12, 0.43], v=.006).  
For HRQoL (Ncomp = 7, N= 406 participants), the random effects model produced a 
significant, small effect size of g= 0.31 (95% CI = 0.07, 0.5), v=.013, p=.013 (Figure 5). 
Significant heterogeneity was present, Q= 14.96, p=.021, I2=59.91. The Fail-Safe N was 25, 
which is less than the criterion of 5k+10, suggesting that this effect is not particularly robust 
and is susceptible to publication bias. For eating disorder-specific HRQoL (Ncomp=5), a 
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significant medium effect size was observed (g= 0.26 [95% CI = 0.001, 0.51], v=.017). The 
CIA (g= 0.34, 95% CI [0.09, 0.71], v=.025), but not the IWQoL (g= 0.21, 95% CI [-0.16, 
0.57], v=.035), produced a statistically significant effect size.  
 Subgroup analyses were then conducted for the between groups post-treatment effect 
size for subjective QoL and HRQoL. Table 4 presents the pooled post-treatment effect size 
for each subgroup of studies. Only one moderation effect was found; the effect size for 
HRQoL at post-treatment was significantly larger when studies reported completer data as 
opposed to ITT data. Comparison type, diagnosis, treatment type, or study quality did not 
moderate the observed effect size.  
 Follow-up effect size. When comparing CBT to any comparison condition, the 
between groups random effects model for subjective QoL produced a significant, small effect 
size of g= 0.33 (95% CI = 0.07, 0.57), v= .016, Z= 2.55, p=.011 (Ncomp = 8, N= 605 
participants). There was significant heterogeneity present, Q= 15.01, p= .036, I2=53.34. This 
effect was not particularly robust, as indicated by a Fail-Safe N of 24. When the SAS (Ncomp= 
5) was used as an outcome, a non-significant effect size was observed (g=0.11, 95% CI [-
0.08, 0.29], v=.010).   
For HRQoL (Ncomp= 6, N= 337 participants), we observed a statistically significant 
small effect size of g= 0.28 (95% CI= 0.11, 0.44), v= .007, Z= 3.27, p=.001. There was no 
significant heterogeneity (Q= 4.34, p= .501, I2=0.00). This effect size was not robust to 
publication bias (Fail-Safe N= 12). A non-significant small effect size was observed for 
eating disorder-specific HRQoL measures (g= 0.23 [95% CI= -0.06, 0.52], v=.022). A non-
significant effect size was also observed when the IWQoL (g= 0.38, 95% CI [-0.21, 0.94], 
v=.089) and CIA (g= 0.12, 95% CI [-0.22, 0.45], v=.030) was used. There were not enough 
studies to assess generic HRQoL measures. Given that there were only a small number of 
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studies that contributed to the between group effect size at follow-up, subgroup analyses for 
follow-up outcomes were not conducted.  
Discussion 
This meta-analysis examined the effects of CBT for eating disorders on QoL. From 
pre-treatment to post-treatment and follow-up, medium to large effect sizes were observed for 
subjective and HRQoL improvements following CBT for eating disorders. The magnitude of 
QoL improvements for eating disorders is larger than the effect size observed from a meta-
analysis of pre-post changes in QoL (d = 0.36) following CBT for bipolar disorder31, but 
similar to the effect size reported on QoL improvements following CBT (g = 0.54) for 
anxiety disorders32. Thus, it seems that CBT for eating disorders produces similar 
improvements in QoL as does CBT for other psychiatric conditions. Moreover, given that a 
previous meta-analysis of CBT for BED33 has observed much larger pre-post effect sizes for 
improvements in eating disorder psychopathology (d’s range from 0.98 to 1.46) it seems that 
CBT is not as effective at improving QoL as it is at reducing eating disorder symptoms. This 
is not unexpected, as CBT is designed specifically to target eating disorder symptoms28, and 
improvements in QoL are a likely consequence of this symptom improvement. 
Moderators were observed for pre-post QoL improvements. First, subjective QoL 
improvements were greatest when CBT was therapist-led as opposed to when CBT was 
delivered in a group or in self-help format. Unlike group or self-help formats, many therapist-
led protocols are implemented flexibly 29, meaning that the treatment is tailored toward 
specific psychological an progress. A more focused treatment where the content and duration 
is determined by the particular psychopathology might therefore account for these effects. 
Also, more treatment sessions were consistently provided in studies that delivered therapist-
led CBT (Msessions= 19.40, SD=0.52) as opposed to studies that delivered group-based 
(Msessions=13.87, SD=5.31) or guided self-help CBT (Msessions=8.75, SD=2.50), suggesting that 
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a dose-response relationship might also exist. That is, more client-therapist contact might be 
an important factor contributing to greater subjective QoL improvements, though this is an 
empirical question that warrants further investigation. Second, HRQoL improvements were 
larger when Fairburn and colleagues’ CBT-BN or CBT-E was delivered. The cognitive 
model underlying CBT-BN and CBT-E has received extensive empirical support34, and the 
efficacy of this treatment has been consistently established9. Because pre-post symptom 
improvement following this manualized CBT tends to be greater and more rapid than other 
CBT protocols, the current results suggest that the short-term beneficial effects of CBT-BN 
and CBT-E also extend to HRQoL indices.    
These moderation effects, however, were not observed at follow-up. Since a smaller 
number of studies contributed to the analyses at follow-up relative to post-treatment, we may 
have lacked sufficient statistical power to detect significant effects24. Alternatively, QoL 
improvements from other CBT modalities or protocols might “catch up” to therapist-led CBT 
or manualized CBT-BN (or CBT-E) in the long-term. For instance, several studies have 
shown that while therapist-led CBT produces significantly greater rates of recovery at post-
treatment than guided self-help CBT for BED, this difference generally disappears at 12 
month follow-up35, 36. Indeed, the observed effect sizes of QoL improvements for self-help 
and group-based CBT were larger at follow-up than at post-treatment, providing preliminary 
support for the idea other CBT modalities take longer than therapist-led manualized CBT to 
achieve its beneficial effects.  
We also observed greater pre-post HRQoL improvements in transdiagnostic samples 
as oppose to AN or BED samples. The difficulty in engaging and treating AN with CBT37 
might explain why we observed a non-significant, small pre-post effect size on HRQoL for 
this population. Moreover, individuals with AN tend to report similar levels of HRQoL 
impairment than healthy controls, which is said to be a result of the egosyntonicity of 
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behaviours associated with AN2. Thus, QoL scores might have less room for improvement in 
AN relative to other eating disorders.  On the other hand, individuals with BED tend to report 
the poorest HRQoL across the eating disorders2, which has been attributed to impairments in 
physical functioning due to overweight and the experiences of weight-related stigma. The 
findings that weight loss following CBT for BED is modest at best 38, and that HRQoL 
impairment in BED has shown to be a result of obesity-related factors2, may also explain why 
CBT results in small HRQoL improvements relative to transdiagnostic samples.  
  
Critically, the pre-post effect sizes discussed above were based on both uncontrolled 
and controlled studies. Including uncontrolled studies means that it is not possible to identify 
which proportion of the effect size can be attributed to the intervention and which to other 
extraneous variables (e.g., expectations, spontaneous recovery) 16. Since RCTs are necessary 
to establish CBTs efficacy on QoL improvements, we ensured that our controlled effect sizes 
were only based on the available RCTs. Thus, interpretations regarding the efficacy of CBT 
for eating disorders on QoL should be primarily based on our findings from these controlled 
effect sizes.  
For controlled effect sizes, CBT was compared against comparison conditions (i.e., 
active psychological comparisons and wait-list controls) to observe its relative effect on QoL. 
A small effect favouring CBT over any comparison was observed for subjective QoL and 
HRQoL. However, publication bias was evident for HRQoL outcomes due to the small 
number of comparisons, which means that this finding is only preliminary and warrants 
further investigation. The observed effect sizes for subjective QoL and HRQoL is much 
smaller than the between-groups effect sizes reported in meta-analyses on the effect of CBT 
for depression and anxiety on QoL (g’s = 0.48-0.56)32, 39. Together, this suggests that the 
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effects of CBT for eating disorders on QoL reported in controlled trials are not as strong as 
the effects of CBT for depression and anxiety on QoL observed in controlled trials.  
We also compared CBT to both inactive (e.g., wait-list) and active (e.g., 
psychotherapy, psychoeducation) comparisons. CBT was superior to inactive and active 
comparison conditions on subjective QoL, suggesting that CBT has a unique effect on 
increasing general wellbeing and life satisfaction. CBT was only superior to inactive 
comparisons on HRQoL improvements. Although CBT was not superior to active 
comparisons on HRQoL scores, this analysis included only three studies, which means that 
this analysis was likely underpowered. To better understand the impact of CBT on HRQoL 
relative to other psychological treatments, future trials of CBT should assess changes in both 
generic and eating disorder-specific HRQoL.  
 Certain limitations to this meta-analysis need to be considered. First, the limited 
number of studies prevented us from analysing specific QoL domains (e.g., physical health, 
mental health). Therefore, we could not pinpoint precisely which QoL domain did or did not 
improve following CBT. Understanding which QoL does not improve following CBT is 
important for treatment planning, as adjunctive treatments could be offered alongside CBT. 
Second, the limited number of RCTs prevented us from comparing CBT to specific 
psychological treatments (e.g., IPT, supportive therapy). This means that we cannot conclude 
that CBT is the most effective psychotherapy approach for improving QoL in individuals 
with eating disorders. Similarly, analyses were based on studies that delivered different CBT 
modalities and intensities to a variety of eating disorder diagnoses. Although eating disorders 
share common features (e.g., shape and weight over-evaluation), many characteristics also 
differ across diagnoses (e.g., weight status, starvation syndrome), meaning that, at times, 
certain eating disorder types require, and even respond better to, more intensive treatment 
programs 10, 11. The limited number of included studies therefore prevented us from 
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examining whether the effects of specific intensities of CBT on QoL differs systematically 
across eating disorder diagnoses.  
Another important limitation was that all included studies assessed QoL change via 
participant self-report. While the self-report questionnaires used had adequate psychometric 
properties, the assessment of QoL change depended solely on the participants self-report, 
thereby introducing potential biases. The biases are prominent in individuals who lack insight 
into the nature of their eating disorder – a feature that is very common in individuals with AN 
and BN 40. When assessed, these individuals may not therefore provide accurate information. 
Because of this, other objective indicators might provide a better assessment of QoL. For 
instance, assessing the effect of CBT in the long-term on disability adjusted life years or 
occupational or educational absenteeism might provide a more accurate assessment of QoL 
change following eating disorder treatments.  
In summary, this study provides preliminary evidence that CBT leads to modest 
improvements in QoL in individuals with eating disorders.  This study also provides initial 
evidence to suggest that CBT is more effective than inactive and active comparisons at 
improving specific domains of QoL (e.g., subjective QoL). However, the small number of 
RCTs that have assessed QoL changes prevent robust conclusions regarding the efficacy of 
CBT for eating disorders on QoL. Future RCTs of CBT for eating disorders should assess 
incorporate subjective, objective and HRQoL measures so that comparisons between various 
CBT formats to specific psychological treatments (CBT, behaviour therapy) can be made. 
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Table 1 
Characteristics of the RCTs that Met Full Inclusion Criteria  
Study  Study Quality Rating  Design Sample CBT intervention (n) Comparison (n) Measure QoL type  
 D1 D2 D3 D4 D5 D6 G       
Agras, Walsh 41 M S W M S M M RCT BN Individual therapist-led CBT-
BN (110) 
Individual therapist-led 
IPT (110) 
SAS Subjective  
Banasiak, Paxton 42 W S S M S M M RCT BN CBT GSH (54) Wait-list (55) SAS Subjective 
Carrard, Crépin 43 M S W W S M W RCT BED CBT internet-based GSH 
(37) 
Wait-list (37) IWQOL HRQoL 
(disease-
specific) 
Chen, Touyz 44 M S S S S M S RCT BN Group CBT-BN (30) 
Individual therapist-led CBT-
BN (30) 
- SAS Subjective 
Davis, McVey 45 M S M M S M S RCT BN Individual therapist-led CBT 
(39) 
Psychoeducation only 
(19) 
SAS Subjective 
 
Durand and King 46 
 
W 
 
S 
 
S 
 
W 
 
S 
 
M 
 
W 
 
RCT 
 
BN 
 
CBT GSH (34) 
 
Specialist treatment (34) 
 
SAS 
Subjective 
Fairburn, Bailey-
Straebler 47 
M S S M S M S RCT Mixed Individual therapist-led CBT-
E (65) 
Individual therapist-led 
IPT (65) 
CIA HRQoL 
(disease-
specific) 
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Table 1 
Characteristics of the RCTs that Met Full Inclusion Criteria  
Study  Study Quality Rating  Design Sample CBT intervention (n) Comparison (n) Measure QoL type  
 D1 D2 D3 D4 D5 D6 G       
Fairburn, Jones 48 M M M M S S S RCT BN Individual therapist-led CBT-
BN (25) 
Individual therapist-led 
IPT (25) 
SAS Subjective 
Fairburn, Kirk 49 M S W M S S M RCT BN Individual therapist-led CBT-
BN (11) 
Individual STFP (11) SAS Subjective 
Fischer, Meyer 50 M M M W S S M RCT BED Group CBT (20) Wait-list (21) QLS Subjective 
Garner, Rockert 51 M M S W S S M RCT BN Individual therapist-led CBT 
(30) 
SET (30) SAS Subjective 
Ghaderi and Scott 52 W M S M S M M RCT Mixed CBT GSH  (15) 
CBT PSH (16) 
- SAS Subjective 
Goldbloom, Olmsted 53 M S W M S M M RCT BN Individual therapist-led CBT-
BN (24) 
Fluoxetine (23) 
Fluoxetine + CBT-BN 
(29) 
SAS Subjective 
Lavender, Startup 54 M S S M S M S RCT Mixed Group CBT (35) ESMT (35) CIA HRQoL 
(disease-
specific) 
 
Ljotsson, Lundin 55 
 
W 
 
S 
 
S 
 
M 
 
S 
 
S 
 
M 
 
RCT 
 
Mixed 
 
CBT internet GSH (35) 
 
Wait-list (34) 
 
SLS 
Subjective 
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Table 1 
Characteristics of the RCTs that Met Full Inclusion Criteria  
Study  Study Quality Rating  Design Sample CBT intervention (n) Comparison (n) Measure QoL type  
 D1 D2 D3 D4 D5 D6 G       
Mitchell, Crosby 56 M S W M S M M RCT Mixed Individual therapist-led CBT-
BN (66) 
CBT-BN Telemedicine (66) 
- SF-36 HRQoL 
(generic) 
Munsch, Biedert 57 W M S W S M W RCT BED Group CBT (44) Group BWL (36) QLS Subjective 
Peterson, Mitchell 58 M S W M S M M RCT BED Individual therapist-led CBT-
BN (60) 
Individual therapist-assisted 
CBT-BN (63) 
CBT GSH (67) 
Wait-list (69) IWQOL HRQoL 
(disease-
specific) 
Sánchez-Ortiz, Munro 
59 
M S S M S S S RCT Mixed CBT internet GSH (38) Wait-list (38) WHO-
QOL 
HRQoL 
(generic) 
Schlup, Munsch 60 W M W W S M W RCT BED Group CBT (18) Wait-list (18) SWLS Subjective 
Striegel-Moore, Wilson 
61 
M S S M S M S RCT Mixed CBT GSH (59) TAU (64) WSAS Subjective 
ter Huurne, de Haan 62 W S M M S M M RCT Mixed CBT GSH (108) Wait-list (106) EQ-5D 
VAS 
Subjective 
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Table 1 
Characteristics of the RCTs that Met Full Inclusion Criteria  
Study  Study Quality Rating  Design Sample CBT intervention (n) Comparison (n) Measure QoL type  
 D1 D2 D3 D4 D5 D6 G       
Touyz, Le Grange 63 M S S M S S S RCT AN Individual therapist-led CBT-
AN (31) 
SSCM (32) SF-36 HRQoL 
(generic) 
Wilfley, Welch 64 W S S M S S M RCT BED Group CBT-BN (81) Group IPT (81) SAS Subjective 
Note: M= Moderate; S = Strong; W= weak rating;  D= domain; D1= selection bias; D2= Study design; D3= Confounders; D4= Blinding; D5= Data collection method; D6= Withdrawal and dropouts; 
G= Global quality rating; n = the number of participants allocated to treatment condition; BED = Binge eating disorder; AN = anorexia Nervosa; BN = Bulimia nervosa; IPT= interpersonal 
psychotherapy; BWL= behavioural weight loss; SSCM=Specialist supportive clinical management; SET= Supportive expressive therapy; TAU= treatment as usual; STFT= short-term focal 
psychotherapy; PSH= pure self-help; TA= therapist-assisted; TL= therapist-led; QLS= questionnaire on life satisfaction; SLS= Satisfaction with life scale; CIA= clinical impairment assessment; SF-
36= short-form 36; SWS= satisfaction with life scale; IWQOL= Impact of weight on quality of life; WSAS= work and social adjustment scale  
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Table 2 
Characteristics of non-RCTs that Met Full Inclusion Criteria  
Study  Study Quality Rating  Design Sample CBT intervention (n) Measure QoL type  
 D1 D2 D3 D4 D5 D6 G      
Abilés, Rodríguez-Ruiz 65 M M NA NA S W M PrePost BED Group CBT-BN (49) QoL Index Subjective  
Byrne, Fursland 66 M M NA NA S W M PrePost Mixed Individual therapist-led CBT-E (125) QLESQ Subjective 
Carrard, Crépin 67 W M S W S S W Non- 
RCT 
BED CBT internet-based GSH (22) IWQOL HRQoL  
(disease-specific) 
Carter, Yanykulovitch-Levy 
68 
W M NA NA S W W PrePost Mixed Group CBT-BN (64) CIA HRQoL  
(disease-specific) 
Hepburn and Clark-Stone 69 M M NA NA S M M PrePost Mixed Group CBT day program (52) CIA HRQoL  
(disease-specific) 
Morgan, Lazarova 70 M M NA NA S S S PrePost AN Individual CBT body image therapy (55) EDQOL HRQoL  
(disease-specific) 
Turner, Marshall 71 M M NA NA S W M PrePost Mixed Individual therapist-led CBT-E (117) CIA HRQoL  
(disease-specific) 
Vancampfort, Probst 72 
 
M M NA NA S S S PrePost BED Group CBT + physical activity (34) SF-36 HRQoL  
(generic) 
Watson, Allen 73 M M NA NA S W M PrePost Mixed Individual therapist-led CBT-E (196) QLESQ Subjective 
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Zandberg and Wilson 74 M M NA NA S M S PrePost BED CBT GSH (34) CIA HRQoL  
(disease-specific) 
Note: M= Moderate; S = Strong; W= weak rating;  D= domain; D1= selection bias; D2= Study design; D3= Confounders; D4= Blinding; D5= Data collection method; D6= Withdrawal and 
dropouts; G= Global quality rating; n = the number of participants allocated to treatment condition; BED = Binge eating disorder; AN = anorexia Nervosa; BN = Bulimia nervosa; PSH= pure self-
help; TA= therapist-assisted; TL= therapist-led; QLS= questionnaire on life satisfaction; SLS= Satisfaction with life scale; CIA= clinical impairment assessment; SF-36= short-form 36; SWS= 
satisfaction with life scale; IWQOL= Impact of weight on quality of life; WSAS= work and social adjustment scale 
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Group by
QoL Measurement
Study name Statistics for each study Hedges's g and 95% CI
Hedges's Lower Upper 
g Variance limit limit p-Value
HRQOL Touyz et al 2013 0.17 0.07 -0.33 0.67 0.508
HRQOL Mitchell et al 2008a 0.55 0.12 -0.13 1.23 0.113
HRQOL Vancampfort et al 2014 0.60 0.02 0.32 0.87 0.000
HRQOL Sanchez et al 2011 0.61 0.03 0.26 0.95 0.001
HRQOL Carrard et al 2011b 0.65 0.01 0.49 0.81 0.000
HRQOL Carter et al 2016 0.77 0.00 0.66 0.89 0.000
HRQOL Hepburn et al 2016 0.81 0.00 0.69 0.94 0.000
HRQOL Fairburn et al 2015 1.52 0.00 1.39 1.65 0.000
HRQOL Peterson et al 2009a 0.25 0.00 0.16 0.34 0.000
HRQOL Carrard et al 2011a 0.29 0.00 0.17 0.40 0.000
HRQOL Peterson et al 2009c 0.29 0.00 0.20 0.38 0.000
HRQOL Peterson et al 2009b 0.30 0.00 0.21 0.40 0.000
HRQOL Mitchell et al 2008b 0.31 0.05 -0.14 0.76 0.182
HRQOL Morgan et al 2014 0.48 0.00 0.38 0.58 0.000
HRQOL Turner et al 2015 0.52 0.00 0.45 0.59 0.000
HRQOL Zandberg et al 2013 0.53 0.00 0.41 0.66 0.000
HRQOL 0.55 0.00 0.42 0.69 0.000
Subjective QoL Chen et al 2003a 0.17 0.01 -0.06 0.41 0.144
Subjective QoL Durand et al 2003 0.21 0.01 -0.01 0.43 0.065
Subjective QoL Abiles et al  2013 0.27 0.01 0.05 0.49 0.015
Subjective QoL Fischer et al 2014 0.27 0.03 -0.06 0.60 0.110
Subjective QoL Byrne et al 2011 0.37 0.00 0.30 0.44 0.000
Subjective QoL Munsch et al 2007 0.38 0.02 0.08 0.69 0.015
Subjective QoL Striegel-Moore et al 2010 0.38 0.01 0.19 0.57 0.000
Subjective QoL ter Huurne et al  2015 0.38 0.01 0.23 0.53 0.000
Subjective QoL Ghaderi et al 2003 0.44 0.03 0.07 0.80 0.019
Subjective QoL Watson et al 2011 0.48 0.00 0.43 0.54 0.000
Subjective QoL Banasiak et al  2005 0.49 0.01 0.32 0.65 0.000
Subjective QoL Schlup et al 2009 0.54 0.04 0.15 0.93 0.007
Subjective QoL Garner et al 1993 0.58 0.02 0.27 0.88 0.000
Subjective QoL Ljotsson et al 2007 0.59 0.01 0.37 0.80 0.000
Subjective QoL Wilfley et al  2002 0.59 0.01 0.44 0.75 0.000
Subjective QoL Chen et al 2003b 0.64 0.02 0.39 0.90 0.000
Subjective QoL Davis et al 1999 0.71 0.01 0.48 0.94 0.000
Subjective QoL Agras et al 2000 0.74 0.01 0.56 0.92 0.000
Subjective QoL Fairburn et al 1991 0.87 0.03 0.55 1.20 0.000
Subjective QoL Fairburn et al 1986 1.13 0.06 0.65 1.61 0.000
Subjective QoL 0.50 0.00 0.38 0.62 0.000
-2.00 -1.00 0.00 1.00 2.00
Decrements Improvements
Figure 2: Meta-analysis of studies that contributed to the effect size on pre-post subjective and HRQoL improvements. 
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Group by
QoL Measurement
Study name Statistics for each study Hedges's g and 95% CI
Hedges's Lower Upper 
g Variance limit limit p-Value
HRQoL Carrard 2011a -0.01 0.05 -0.46 0.45 0.980
HRQoL Peterson 0.08 0.01 -0.13 0.30 0.451
HRQoL Touyz 2013 0.12 0.02 -0.16 0.40 0.397
HRQoL Lavender 2012 0.16 0.09 -0.42 0.74 0.597
HRQoL Fairburn 2015 0.49 0.03 0.13 0.86 0.008
HRQoL Sanchez-Ortiz 2011 0.74 0.04 0.35 1.14 0.000
HRQoL Carrard 2011b 0.80 0.10 0.17 1.43 0.013
HRQoL 0.31 0.01 0.07 0.54 0.010
Subjective Durand 2003 0.00 0.06 -0.47 0.47 1.000
Subjective Munsch 2007 0.18 0.08 -0.38 0.74 0.530
Subjective Wilfley 2002 0.20 0.03 -0.11 0.51 0.210
Subjective Davis 1999 0.23 0.08 -0.32 0.77 0.412
Subjective Ter Huurne 2015 0.25 0.02 -0.02 0.51 0.072
Subjective Agras 2000 0.25 0.03 -0.10 0.59 0.157
Subjective Fairburn 1991 0.25 0.09 -0.34 0.85 0.407
Subjective Ljotsson 2007 0.37 0.06 -0.11 0.84 0.133
Subjective Garner 1993 0.39 0.10 -0.21 1.00 0.205
Subjective Fairburn 1986 0.41 0.17 -0.41 1.22 0.328
Subjective Banasiak 2005 0.57 0.04 0.19 0.95 0.004
Subjective Schlup 0.83 0.14 0.09 1.58 0.028
Subjective Striegel-Moore 2010 1.23 0.04 0.84 1.61 0.000
Subjective 0.39 0.01 0.20 0.57 0.000
-2.00 -1.00 0.00 1.00 2.00
Favours comparitorFavours CBT
Figure 3: Meta-analysis of RCTon QoL at Post-treatment
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Table 3 
Moderator Analyses for Within-Group Effects at Post-Treatment and Follow-Up 
  Subjective QoL  HRQoL 
Moderator  Ncomp  g (95% CI) Qbetween p  Ncomp  g (95% CI) Qbetween    p 
Study Design            
  Pre-Post treatment2           
     RCT 17 .51 (.43, .59)    9 .48 (.25, .72)   
 Pre-Post 4 .44 (.29, .55)    6 .64 (.36, .91)   
    1.17  .279    .69 .405 
Diagnosis            
  Pre-Post treatment           
 Transdiagnostic  7 .45 (.34, .55)    7 .77 (.54, 1.00)   
 BN 9 .56 (.45, .68)    - -   
 BED 5 .42 (.26, .59)    6 .39 (.16, .61)   
 AN - -    2 .37 (-.07, .81)   
    2.89  .235    6.37 .041 
  Pre to follow-up           
 Transdiagnostic  - -    2 .94 (.52, 1.36)   
 BN 6 .69 (.47, .92)    2 .29 (-.23, .81)   
 BED 4 .87 (.56, 1.17)    5 .47 (.21, .74)   
 AN - -      5.49 .139 
    3.73 .154      
Treatment type            
  Pre-post treatment           
 Individual therapist-led 8 .61 (.49, .73)    5 .68 (.34, 1.02)   
 Group therapist-led  6 .37 (.23, .52)    6 .54 (.26, .31)   
 Self-help  7 .43 (.32, .55)    4 .43 (.09, .77)   
    7.29 .026    1.02 .600 
                                                             
2 Study design was not tested as a moderator at follow-up because there were no pre-post studies that assessed QoL changes at follow-up.  
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Table 3 
Moderator Analyses for Within-Group Effects at Post-Treatment and Follow-Up 
  Subjective QoL  HRQoL 
Moderator  Ncomp  g (95% CI) Qbetween p  Ncomp  g (95% CI) Qbetween    p 
  Pre to follow-up           
 Individual therapist-led 4 .74 (.41, 1.08)    6 .43 (.07, .79)   
 Group therapist-led  5 .86 (.54, 1.17)    - -   
 Self-help  2 .86 (.40, 1.33)    4 .64 (.21, 1.06)   
    .28 .868    .51 .476 
Analysis            
   Pre-post treatment           
    ITT 13 .42 (.35, .49)    8 .36 (.21, .53)   
 Completer  8 .65 (.53, .75)    7 .82 (.63, 1.01)   
    11.21 .001    13.32 <.001 
  Pre to follow-up           
 ITT 6 .83 (.57, 1.09)    5 .33 (.11, .55)   
 Completer  5 .79 (.50, 1.08)    5 .77 (.52, 1.02)   
    .04 .830    6.95 .008 
CBT type            
   Pre-post treatment           
    Fairburn’s CBT 13 .52 (.43, .61)    6 .79 (.52, 1.09)   
 Other  8 .43 (.31, .55)    9 .44 (.25, .64)   
    1.31 .452    3.80 .050 
  Pre to follow-up           
 Fairburn’s CBT 6 .83 (.57. 1.07)    3 .71 (.32, 1.09)   
 Other  5 .79 (.50, 1.08)    7 .46 (.23, .68)   
    .03 .855    1.17 .279 
Study Quality            
  Pre-post treatment            
 Strong 6 .53 (.39, .65)    5 .73 (.43, 1.02)   
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Table 3 
Moderator Analyses for Within-Group Effects at Post-Treatment and Follow-Up 
  Subjective QoL  HRQoL 
Moderator  Ncomp  g (95% CI) Qbetween p  Ncomp  g (95% CI) Qbetween    p 
 Moderate 12 .49 (.41, .58)    7 .43 (.18, .67)   
 Weak 3 .34 (.12, .55)    3 .56 (.21, .92(   
    2.28 .319    2.29 .317 
  Pre to follow-up           
 Strong 4 .75 (.44, 1.07)    3 .73 (.45, .99)   
 Moderate 4 1.03 (.69, 1.36)    5 .24 (.02, .46)   
 Weak 3 .61 (.22, .99)    2 .86 (.54, 1.18)   
    2.83 .243    12.76 .002 
 
 
 
 
 
 
Quality of Life 
33 
 
Table 4 
Moderator Analyses for Between-Group Effects at Post-Treatment  
  Subjective QoL  HRQoL  
Moderator  Ncomp  g (95% CI) Qbetween p  Ncomp  g (95% CI) Qbetween   p 
Comparison type             
 Active 9 .36 (.11, .61)    3 .26 (-.13, .65)   
 Inactive 4 .45 (.09, .80)    4 .35 (.01, .69)   
    .17 .678    .12  .735 
Diagnosis            
 Transdiagnostic 3 .60 (.22, .97)    2 .35 (-.19, .90)   
 BN 7 .29 (.01, .57)    - -   
 BED 3 .33 (-.09, .76)    4 .36 (-.01, .72)   
 AN - -    - -   
    1.67 .443    .38 .825 
Treatment type           
 Individual therapist-led 5 .29 (-.06, .64)    2 .30 (-.18, .78)   
 Group therapist-led 3 .33 (-.10, .77)    - -   
 Self-help 5 .48 (.18, .79)    3 .49 (.04, .94)   
    .77 .678    1.24  .742 
Analysis            
 ITT 5 .47 (.18, .76)    3 .08 (-.07, .24)   
 Completer  8 .32 (.06, .58)    4 .56 (.33, .79)   
    .54 .461    11.42 .001 
CBT type           
 Fairburn’s CBT 6 .48 (.20, .77)    2 .36 (-.11, .83)   
 Other 7 .31 (.06, .56)    5 .29 (.02, .56)   
    .85 .357    .07 .796 
Quality Rating           
 Strong 3 .67 (.31, 1.04)    4 .38 (.04, .72)   
 Moderate 7 .32 (.11, .55)    - -   
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Table 4 
Moderator Analyses for Between-Group Effects at Post-Treatment  
  Subjective QoL  HRQoL  
Moderator  Ncomp  g (95% CI) Qbetween p  Ncomp  g (95% CI) Qbetween   p 
 Weak  3 .25 (-.15, .65)    2 .33 (-.21, .88)   
    3.07 .215    .73 .693 
Note: HRQoL = health-related quality of life; RCT= Randomised controlled trial; BN= bulimia nervosa; AN= anorexia nervosa; BED= Binge eating disorder; ITT= Intention 
to treat; Ncomp = number of comparisons. 
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